Literature DB >> 20479897

Plasma 5-hydroxytryptamine concentration and its correlation with psychopathology in patients with irritable bowel syndrome.

Seon-Young Park1, Min-Ho Park, Kyoung-Won Yoon, Sung-Bum Cho, Wan-Sik Lee, Chang-Hwan Park, Hyun-Soo Kim, Sung-Kyu Choi, Jong-Sun Rew.   

Abstract

BACKGROUND/AIMS: Irritable bowel syndrome (IBS) is a biopsychosocial disorder. 5-Hydroxytryptamine (5-HT) plays a crucial role in the control of gastrointestinal motility, sensation, and secretion. This study investigated changes in platelet-depleted plasma 5-HT and their correlation with psychopathology in IBS patients and healthy subjects.
METHODS: This study involved 21 subjects with IBS and 13 healthy subjects. Fasting and 1-hr postprandial plasma 5-HT concentrations were measured. The SCL-90R symptom checklist was used for the assessment of current psychological symptoms.
RESULTS: Fasting and postprandial plasma 5-HT concentrations were significantly higher in IBS patients (15.11+/-13.51 ng/mL and 16.31+/-14.21 ng/mL, respectively) than in healthy subjects (5.55+/-4.14 ng/mL and 6.25+/-4.82 ng/mL, respectively; p<0.05). There were no significant changes between fasting and 1-hr postprandial 5-HT concentration in IBS subtypes and healthy subjects. Scores on all SCL-90R subscales except for the interpersonal-sensitivity subscale were significantly higher in IBS patients than in healthy subjects. No correlation was found between SCL-90R items and platelet-depleted plasma 5-HT concentration.
CONCLUSIONS: 5-HT might play a critical role in IBS, and psychopathological factors are correlated with IBS.

Entities:  

Keywords:  5-hydroxytryptamine; Irritable bowel syndrome; Psychopathology

Year:  2009        PMID: 20479897      PMCID: PMC2871566          DOI: 10.5009/gnl.2009.3.1.26

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  28 in total

Review 1.  Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel.

Authors:  M D Gershon
Journal:  Aliment Pharmacol Ther       Date:  1999-05       Impact factor: 8.171

2.  HYPERSEROTONINEMIA IN FUNCTIONAL GASTROINTESTINAL DISEASE.

Authors:  R R WARNER
Journal:  Ann Intern Med       Date:  1963-10       Impact factor: 25.391

Review 3.  Functional bowel disorders and functional abdominal pain.

Authors:  W G Thompson; G F Longstreth; D A Drossman; K W Heaton; E J Irvine; S A Müller-Lissner
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

4.  5-HT released by mucosal stimuli initiates peristalsis by activating 5-HT4/5-HT1p receptors on sensory CGRP neurons.

Authors:  J R Grider; J F Kuemmerle; J G Jin
Journal:  Am J Physiol       Date:  1996-05

5.  Variation of muscle tone in the human colon.

Authors:  C J Steadman; S F Phillips; M Camilleri; A C Haddad; R B Hanson
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682

6.  Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study.

Authors:  C P Bearcroft; D Perrett; M J Farthing
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

Review 7.  Quality of life issues in patients with inflammatory bowel disease.

Authors:  E J Irvine
Journal:  Am J Gastroenterol       Date:  1997-12       Impact factor: 10.864

8.  Impact of irritable bowel syndrome on quality of life.

Authors:  W E Whitehead; C K Burnett; E W Cook; E Taub
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

9.  U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact.

Authors:  D A Drossman; Z Li; E Andruzzi; R D Temple; N J Talley; W G Thompson; W E Whitehead; J Janssens; P Funch-Jensen; E Corazziari
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

10.  Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study.

Authors:  G Ragnarsson; G Bodemar
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-05       Impact factor: 2.566

View more
  3 in total

1.  Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis.

Authors:  Mei Luo; Xiaojun Zhuang; Zhenyi Tian; Lishou Xiong
Journal:  BMC Gastroenterol       Date:  2021-01-06       Impact factor: 3.067

Review 2.  Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders.

Authors:  Hirokazu Fukui; Xin Xu; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2018-07-30       Impact factor: 4.924

3.  Associations of neurotransmitters and the gut microbiome with emotional distress in mixed type of irritable bowel syndrome.

Authors:  Zahra A Barandouzi; Joochul Lee; Maria Del Carmen Rosas; Jie Chen; Wendy A Henderson; Angela R Starkweather; Xiaomei S Cong
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.